Returning to pulmonary hypertension, GSK buys 35Pharma
Returning to pulmonary hypertension, GSK buys 35Pharma
Body unavailable. Use the original source.
Returning to pulmonary hypertension, GSK buys 35Pharma
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.